Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality

Elizabeth Ann Grimm

doi:10.1016/0304-419X(86)90017-X

Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality

Elizabeth Ann Grimm

Melanoma Medical Oncology

Research output: Contribution to journal › Review article › peer-review

70 Scopus citations

Original language	English (US)
Pages (from-to)	267-279
Number of pages	13
Journal	BBA - Reviews on Cancer
Volume	865
Issue number	3
DOIs	https://doi.org/10.1016/0304-419X(86)90017-X
State	Published - Dec 17 1986

ASJC Scopus subject areas

Oncology
Genetics
Cancer Research

Access to Document

10.1016/0304-419X(86)90017-X

Cite this

@article{11d78508648340d49f8ea331ba7403ce,

title = "Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality",

author = "{Ann Grimm}, Elizabeth",

year = "1986",

month = dec,

day = "17",

doi = "10.1016/0304-419X(86)90017-X",

language = "English (US)",

volume = "865",

pages = "267--279",

journal = "BBA - Reviews on Cancer",

issn = "0304-419X",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality

AU - Ann Grimm, Elizabeth

PY - 1986/12/17

Y1 - 1986/12/17

UR - http://www.scopus.com/inward/record.url?scp=0022914307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022914307&partnerID=8YFLogxK

U2 - 10.1016/0304-419X(86)90017-X

DO - 10.1016/0304-419X(86)90017-X

M3 - Review article

C2 - 3539198

AN - SCOPUS:0022914307

SN - 0304-419X

VL - 865

SP - 267

EP - 279

JO - BBA - Reviews on Cancer

JF - BBA - Reviews on Cancer

IS - 3

ER -

Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this